Year: 2019
Type: article
Abstract: Clinical trial regulations should remove unnecessary obstacles for the conduct of pragmatic trials assessing the comparative effectiveness of medicines posing no or minimal risk to participants, say Rafael Dal-Ré and colleagues
Source: BMJ
DOI: 10.1136/bmj.l1092
Institutions: Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Hospital Universitario Puerta de Hierro Majadahonda, Medical University of Vienna, Utrecht University, Uppsala University, University of Cologne, University Hospital Cologne, University of Manchester, Duke University, Duke Medical Center, University of Pavia, Leiden University Medical Center, University of Aberdeen
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Universiteit Leiden
OpenAlex ID: W2923535673